Zhang, Y., Chen, R., Jia, Y., Chen, M
Your healthcare provider may recommend dose adjustments, medication timing changes, or a trial of an alternative GLP-1 compound
The six-month plan at $179 brings the monthly cost below $30 , making it a strong value for users with more ambitious weight loss goals
This decrease was significantly greater than those in the placebo group, who lost an average of 2.4% in the same period
CVS Caremark's decision is not in the best interest of patients, and heres why: Zepbound Demonstrates Superior Efficacy : Clinical evidence, most notably the head-to-head SURMOUNT-5 trial, showed that patients on Zepbound achieved significantly greater average weight loss (20.2%) compared to those on Wegovy (13.7%) over 72 weeks